Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

NCT06527534 ·Status: RECRUITING ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy

NCT04115839 ·Status: TERMINATED ·Phase: PHASE3

An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

NCT01615419 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

NCT04115748 ·Status: TERMINATED ·Phase: PHASE3

Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

NCT01559103 ·Status: TERMINATED ·Phase: PHASE1

A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

NCT05487703 ·Status: COMPLETED

Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

NCT05090410 ·Status: UNKNOWN ·Phase: PHASE3

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

NCT03320876 ·Status: TERMINATED ·Phase: PHASE2

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

NCT02886728 ·Status: COMPLETED ·Phase: PHASE3

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

NCT04413617 ·Status: COMPLETED ·Phase: PHASE2

A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

NCT01705730 ·Status: COMPLETED

Objective Study in Rheumatoid Arthritis

NCT00451971 ·Status: COMPLETED ·Phase: PHASE4

A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

NCT06625242 ·Status: COMPLETED ·Phase: PHASE4

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

NCT02065700 ·Status: COMPLETED ·Phase: PHASE2

Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

NCT03073109 ·Status: COMPLETED

A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

NCT01617005 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy

NCT04483700 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis

NCT03926195 ·Status: COMPLETED ·Phase: PHASE2

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis

NCT05502731 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function

NCT03417778 ·Status: COMPLETED ·Phase: PHASE1

Rheumatoid Arthritis Response to Methotrexate

NCT03535519 ·Status: UNKNOWN

Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis

NCT02504671 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis

NCT06073093 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis

NCT02919761 ·Status: COMPLETED ·Phase: PHASE4